BioSyent Inc.
BioSyent Inc. scores highest on Nitro (93) and lowest on Price (41). Its PosiPenta is 66.13 out of 100, better than most similar companies.
On the Penta Grid this week, BioSyent Inc. is Grid #1 of 8 in the Healthcare sector in Canada, and Grid #15 of 130 in Canada.
Compared with similar companies in the Healthcare sector in Canada.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| BioSyent Inc. | 66.13 | 41 | 56 | 93 | 67 | 74 |
| Organigram Global Inc. | 57.94 | 91 | 54 | 29 | 66 | 49 |
| Cipher Pharmaceuticals Inc. | 64.27 | 71 | 59 | 44 | 76 | 72 |
| COSCIENS Biopharma Inc. | 27.32 | 46 | 0 | 16 | 36 | 38 |
| Quest PharmaTech Inc. | 59.22 | 98 | 84 | 17 | 69 | 27 |
| Zero Candida Technologies, Inc. | 30.60 | 0 | 36 | 15 | 56 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 19.64 |
| P/B ratio | 4.09 |
EEarnings
| Trailing EPS | ₹57.77 |
| Forward EPS | ₹38.06 |
NNitro
| Price | 1134.23 |
| 52-week high | 1189.28 |
| 52-week low | 723.76 |
| Fall from 52-week high | 4.6% |
TTorque
| Return on equity (ROE) | 23.65% |
| Debt-to-equity | 0.07 |
AAnchor
| Beta (price swings) | 0.59 |
| Market cap | ₹1,274 Cr |
| Insider holding | 34.95% |
| Dividend yield | 1.32% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is BioSyent Inc.'s PosiPenta score?
BioSyent Inc.'s PosiPenta is 66.13 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does BioSyent Inc. stand on the Penta Grid?
On the Penta Grid this week, BioSyent Inc. is Grid #1 of 8 in the Healthcare sector in Canada, and Grid #15 of 130 in Canada.
Which PosiPenta pillar is strongest for BioSyent Inc.?
Nitro (momentum), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for BioSyent Inc.?
Price (valuation), with a score of 41 out of 100: around the middle of similar companies.
PositoAI is for research and education only and is not investment advice.